Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q3 2016 · 10-Q
Revenue$236.06K$236.06K+7.7% vs Q3 2015 Net Income-$11.85K-$11.85KN/M vs Q3 2015 EPS Diluted$0.00$0.00— vs Q3 2015 Gross Profit$122,487+22.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flowderived$15,980+212.0% Free Cash Flowderived$254−41.2% Margins · derivedGross margin51.9%+6.2 pt vs Q3 2015
Operating margin-5.2%+3.8 pt vs Q3 2015
Net margin-5.0%+3.6 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 21, 2016 · 52 d after period end